@ValterMPinto

Managing Director at KCSA

 New York, NY
KCSA.com
Joined March 2009
  • Tweets690
  • Following891
  • Followers216
18Media
Valter M. Pinto retweeted
NewcelX Ltd@newcelXltdSep 23
@EledonPharma submitted an IND for tegoprubart in T1D islet transplantation. Highly relevant to NewCelX ($NCEL): our NCEL-101 program is being developed with tegoprubart as part of an immune-protection strategy. #T1D #CellTherapy #Biotech
2
3
70
Valter M. Pinto retweeted
Co-Diagnostics Inc@Co_DiagnosticsSep 16
Co-Diagnostics and ReadyGo are collaborating on blood-based molecular testing at the point of need, starting with Ebola. Feasibility work is underway. $CODX ir.co-dx.com/2026-09-16-Co-D…
🤖 Made with AI
2
2
2
8
1,192
Valter M. Pinto retweeted
Barchart
@BarchartJun 4
A landmark independent study validates ENvue’s platform with improved outcomes, reduced imaging, nursing time savings, and lower costs. Clinical proof + economic value = adoption potential. $FEED @ENvueMedical xitter.cf/i/broadcasts/1pKdRRemr…
🤝 Paid partnership
0:00

Barchart

A landmark independent study validates ENvue’s platform with improved outcomes, reduced imaging, nursing time savings, and lower costs. Clinical proof + economic value = adoption potential. $FEED @ENvueMedical

20
8
1
28
15,701
Valter M. Pinto retweeted
Jason Wild
@JasonGWildJun 4
I ❤️New York (Stock Exchange)
JT_in_LA
@JT_in_LAJun 4
Waiting on $TSNDF to announce that reverse split. 1 for 15? Make it a $10 stock. Puts the float at around 20 million shares. Uplist that on the big board and it's gonna be fun. @JasonGWild
18
16
5
115
15,265
Valter M. Pinto retweeted
AnthonyConiglio
@AnthonyConigli0May 12
Seven years into our journey and excited to join a curated group of public companies at the Sohn Emerging Company Pavilion. Grateful for the chance to connect with investors supporting both innovation and the fight against pediatric cancer.
3
1
17
4,596
Valter M. Pinto retweeted
Benzinga
@BenzingaApr 30
EXCLUSIVE: NewcelX $NCEL Expects Expanded Strategic Development Collaborations For Diabetes Drug In 2026 $ELDN
3
1
5
1,978
Valter M. Pinto retweeted
TDR
@TheDalesReportApr 30
🗣️ "A lot of it is TBD ... The other news that came out with the rescheduling ... the DOJ put in a recommendation to the treasury to give us back our back taxes." - @JasonGWild Chairman of @terrascendcorp $TSNDF 🎦 WATCH: youtube.com/live/spxPdhTgg5c… 🌿 ETFs: 🌎 $YOLO 🇺🇸 $MSOS
1
5
38
4,457
“Capital likes clarity.” @AnthonyConigli0 joins @TheDalesReport to discuss the April 23 shift to Schedule III—moving cannabis from regulatory uncertainty toward fundamentals like cash flow, balance sheets, and scalable growth as institutional capital looks to re-engage. youtube.com/live/DHyXpzVnzKU… $NLCP

Schedule III Is Official — What Comes Next? | TTB Presented by Flowhub

In our latest Trade To Black podcast, hosts Shadd Dales and Anthony...

youtube.com
3
11
963
Valter M. Pinto retweeted
Brian Rudick
@thetinyantApr 23
Great discussion with @scottmelker on the day’s most important crypto news. Honor to join the show (and in person!) 🙏
The Wolf Of All Streets
@scottmelkerApr 23
Strategy $MSTR won the treasury narrative.
10
3
29
18,663
Valter M. Pinto retweeted
Eric Jackson
@ericjacksonApr 22
SRXH just invested in Astro Investment XVII, an affiliate of Astro Capital. 🚀 (Long) globenewswire.com/news-relea…

SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital

Company has invested greater than 10% of its investable capital in the convergence of Artificial Intelligence (“AI”) and space through Astro Capital...

globenewswire.com
30
35
9
225
39,610
Starting soon!
BTCS Inc. (Nasdaq: BTCS)
@NasdaqBTCSApr 6
Join us tomorrow at 2:30 PM EST for BTCS’s second AMA Webinar Series. CEO Charles Allen will break down our Imperium DeFi strategy and why it’s central to BTCS’s vision for 2026. Register for the AMA here: us02web.zoom.us/webinar/regi…
3
4
15
758
How does BTCS approach deploying capital? Here’s our CEO Charles Allen on our strategy when it comes to allocating capital across our business 👇
2
2
7
750
BTCS CEO Charles Allen recently spoke on the Webull Digital Asset Treasury Crypto Webinar about our differentiated strategy and the opportunity we see as an Ethereum-focused company. Watch the webinar here: youtube.com/watch?v=MkL2Z64R…
2
6
629
Valter M. Pinto retweeted
AnthonyConiglio
@AnthonyConigli0Mar 16
What I’m watching this week: Fed likely to hold rates steady; in Virginia, the governor is poised to sign adult‑use sales legislation, setting up the next East Coast rec market; watching a wave of “medical cannabis in hospitals” bills in VA/WA/DE (with CT/HI in the mix) as states quietly normalize end‑of‑life use in healthcare settings.
4
42
1,744
RT @BarchartNews: Big news for $NXGL: A deal set to triple annual revenue to ~$35M and drive immediate profit! By acquiring 6 commercial-st…
1
5
Valter M. Pinto retweeted
Barchart
@BarchartMar 11
Transformative Acquisition, Major Revenue Scale and Path to Profitability: LIVE $NXGL Breakdown #sponsored xitter.cf/i/broadcasts/1qxvvkwvp…
🤝 Paid partnership
1
4
37
43,253
$NXGL Signs Definitive Agreement to License Transformative Portfolio of Regenerative Biomaterial Products $CELU; expected to triple annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing - ir.nexgel.com/news-events/pr…

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-S...

Transaction expected to approximately triple NEXGEL’s annual revenue to about $35 million and is expected to make the Company immediately…...

ir.nexgel.com
1
232
Congrats to @niagenbio $NAGE Reporting 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025 - investors.niagenbioscience.c…

Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income...

Net sales increased 30% year-over-year to $129.4 million in 2025 Gross margin increased 250 bps year-over-year to 64.3% in 2025 Net income increased 103% year-over-year to $17.4 million in 2025...

investors.niagenbioscience.com
1
196
Tomorrow, BTCS will host Part 1 of our new AMA Webinar Series at 2:30 PM ET. Tune in to hear me discuss our capital strategy and how BTCS strategically raises and deploys our assets across the Ethereum ecosystem. Register Here: us02web.zoom.us/webinar/regi…
2
2
14
755
$MCRP Signs $9.3 Million Commercial Development and Multi-Year Distribution Agreement with AfricAI to Expand AI-Driven Autonomous Vehicles Across Africa - investors.micropolis.ai/pr/m…
1
36
Load more